
2C-T-2 - Wikipedia
2C-T-2, also known as 4-ethylthio-2,5-dimethoxyphenethylamine, is a psychedelic and entactogenic phenethylamine of the 2C family. [2] It was first synthesized in 1981 by …
2C-T-2 - PsychonautWiki
2,5-Dimethoxy-4-ethylthiophenethylamine (also known as 2C-T-2, and Rosy) is a psychedelic substance of the phenethylamine chemical class that produces psychedelic effects when …
2C-T - Wikipedia
2C-T, or 2C-T-1, also known as 4-methylthio-2,5-dimethoxyphenethylamine, is a psychedelic and hallucinogenic drug of the 2C family. It is used by some as an entheogen. It has structural and …
Erowid 2C-T-2 (2CT2) Vault
What is "2,5-Dimthoxy-4-ethlthio-pea HCL"? Information about 2C-T-2 including basics, effects, dosage, history, legal status, photos, research, media coverage, and links to other resources.
2C-T-2: Effects, Dosage, How To Take It & More - TrippyWiki
What is 2C-T-2? 2C-T-2 is a psychedelic substance of the phenethylamine class. The drug shares many similarities with a more famous 2C-B and its effects are somewhere between LSD and …
2C-T-2 - Drugs-Forum
2010年8月31日 · 2C-T-2 (4-ethylthio-2,5-dimethoxyphenethylamine) is a psychedelic phenethylamine first described by chemist Alexander Shulgin in his book PiHKAL: A Chemical …
2C-T-2 | C12H19NO2S | CID 12074193 - PubChem
2C-T-2 | C12H19NO2S | CID 12074193 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity …
2C-T-2 - wikidoc
2C-T-2, or 2,5-di methoxy -4- ethyl thio phenethylamine, is a psychedelic and ethneogenic phenethylamine of the 2C family. It was first synthesized in 1981 by Alexander Shulgin. [1] . …
2C-T-2 - precision.fda.gov
This substance record has relationships which can be visualized as a network with other substance records. A simplified representation of that network can be interactively explored …
Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the ...
The risk-assessment reports on the synthetic drugs 2C-I; 2C-T-2 and 2C-T-7 were submitted by the EMCDDA to the European Council and Commission on 4 April 2003. The reports were …